discovery studio 2017 r2 client version 17 (Dassault Systemes)
90
Structured Review
Dassault Systemes
discovery studio 2017 r2 client version 17
Discovery Studio 2017 R2 Client Version 17, supplied by Dassault Systemes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/discovery+studio+2017+r2+client/discovery+studio+modeling+environment+release+2017/10__1016_slash_j__fbio__2024__103692-85-6-13
Average 90 stars, based on 1 article reviews
Discovery Studio 2017 R2 Client Version 17, supplied by Dassault Systemes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/discovery+studio+2017+r2+client/discovery+studio+modeling+environment+release+2017/10__1016_slash_j__fbio__2024__103692-85-6-13
Average 90 stars, based on 1 article reviews
discovery studio 2017 r2 client version 17 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: GINCM-DTA: A graph isomorphic network with protein contact map representation for potential use against COVID-19 and Omicron subvariants BQ.1, BQ.1.1, XBB.1.5, XBB.1.16 Article Snippet: The COVID-19 pandemic’s profound impact on global health and the economy underscores the need for new computational strategies to rapidly identify potential antiviral drugs against emerging and re-emerging infectious diseases.. AI-based drug repurposing methods have the potential to significantly shorten the drug discovery process, rendering them a crucial and efficacious approach for screening anti-SARS-CoV-2 compounds.. In this paper, we proposed GINCM-DTA, an AI-based graph isomorphism network with protein contact map representation for drug–target affinity (DTA) prediction, and presented the COVID-DTA dataset for SARS-CoV-2-specific drug repurposing. Article Title: The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Article Snippet: The interactions were visualized using Construct:Article Title: Rational design of an N-terminal cysteine-containing tetrapeptide that inhibits tyrosinase and evaluation of its mechanism of action Article Snippet: Molecular docking was performed using GOLD Suite 5.5 (Cambridge Crystallographic Data Center, Cambridge, UK) ( ). .. Three-dimensional (3D) structures of peptides were constructed using Software:Article Title: The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Article Snippet: .. The catalytic residues are displayed in CPK and colored green. (Software: Article Title: The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Article Snippet: .. The hydrogen atoms are omitted for the sake of clarity. (Software: Article Title: The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Article Snippet: .. The hydrogen atoms are omitted for the sake of clarity. (Software: Activity Assay:Article Title: The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Article Snippet: .. The hydrogen atoms are omitted for the sake of clarity. (Software: |